Towards therapeutics for Autism Spectrum Disorder using Syngap1 heterozygous mouse model.

Here are our introductory comments:

Dr. James Clement gave a talk on Thursday, October 3rd titled Towards therapeutics for Autism Spectrum Disorder using Syngap1 heterozygous mouse model.

You may also like

64 - SYNGAP Study - Seizure Tracker

Invitae/Ciitizen & Praxis

63 - Targeting alternative splicing of SYNGAP1 using antisense oligonucleotides

Ben Prosser, PhD

University of Pennsylvania

23 - Cognition, behavior & clinical trials in SYNGAP1

Andrew Stanfield, PhD

Univ. of Edinburgh